The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study

PurposeThis study efforts to explore the association between sarcopenia, an age-related decline in muscle mass and physical function, and clinical outcomes in women with triple-negative breast cancer (TNBC).Methods and materialsThis retrospective study included women diagnosed with TNBC who received...

Full description

Saved in:
Bibliographic Details
Main Authors: Huayan Gu, Teng Zhu, JiaLing Ding, Zhi Yang, Yiqiao Lu, Guilong Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1402300/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832087089555963904
author Huayan Gu
Teng Zhu
JiaLing Ding
Zhi Yang
Yiqiao Lu
Guilong Guo
author_facet Huayan Gu
Teng Zhu
JiaLing Ding
Zhi Yang
Yiqiao Lu
Guilong Guo
author_sort Huayan Gu
collection DOAJ
description PurposeThis study efforts to explore the association between sarcopenia, an age-related decline in muscle mass and physical function, and clinical outcomes in women with triple-negative breast cancer (TNBC).Methods and materialsThis retrospective study included women diagnosed with TNBC who received breast surgery from December 2012 to December 2018. Skeletal muscle mass index (SMI) is utilized to evaluate sarcopenia, which was quantified by the cross-sectional area of muscle at the twelfth thoracic vertebra (T12). Disease-free survival (DFS) and overall survival (OS) are the endpoints. The association of sarcopenia with DFS and OS was statistically analyzed.ResultsThe study included 130 women in all, with a median age of 55 years (median follow-up, 53 months). Among them, 78 (58.5%) women had sarcopenia (SMI <28.01). 38 patients (29.2%) died and 49 patients (37.7%) experienced a recurrence of breast cancer throughout the follow-up period. Sarcopenia was demonstrated to be a significant predictive factor for both OS (HR,2.885; 95% CI, 1.349–6.169; p = 0.006) and DFS (HR,3.121; 95% CI, 1.578–6.175; p = 0.001) in the multivariate Cox proportional hazard model. There was no significant correlation seen between body mass index and either DFS (p = 0.156) or OS (P = 0.264). Logistic regression model further revealed that sarcopenia was a prognostic factor that was independently associated with both DFS (p = 0.001) and OS (p = 0.006).ConclusionsAmong women with TNBC, sarcopenia is associated with worse clinical outcomes. These patients with high risk might be candidates for individual programmed exercise and diet interventions to optimize survival outcomes.
format Article
id doaj-art-15f606e20b9f4b4499bf6bb1363aea96
institution Kabale University
issn 2234-943X
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-15f606e20b9f4b4499bf6bb1363aea962025-02-06T07:09:44ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-02-011510.3389/fonc.2025.14023001402300The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective studyHuayan Gu0Teng Zhu1JiaLing Ding2Zhi Yang3Yiqiao Lu4Guilong Guo5Department of Breast Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Gastrointestinal Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Breast Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Breast Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Breast Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Breast Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaPurposeThis study efforts to explore the association between sarcopenia, an age-related decline in muscle mass and physical function, and clinical outcomes in women with triple-negative breast cancer (TNBC).Methods and materialsThis retrospective study included women diagnosed with TNBC who received breast surgery from December 2012 to December 2018. Skeletal muscle mass index (SMI) is utilized to evaluate sarcopenia, which was quantified by the cross-sectional area of muscle at the twelfth thoracic vertebra (T12). Disease-free survival (DFS) and overall survival (OS) are the endpoints. The association of sarcopenia with DFS and OS was statistically analyzed.ResultsThe study included 130 women in all, with a median age of 55 years (median follow-up, 53 months). Among them, 78 (58.5%) women had sarcopenia (SMI <28.01). 38 patients (29.2%) died and 49 patients (37.7%) experienced a recurrence of breast cancer throughout the follow-up period. Sarcopenia was demonstrated to be a significant predictive factor for both OS (HR,2.885; 95% CI, 1.349–6.169; p = 0.006) and DFS (HR,3.121; 95% CI, 1.578–6.175; p = 0.001) in the multivariate Cox proportional hazard model. There was no significant correlation seen between body mass index and either DFS (p = 0.156) or OS (P = 0.264). Logistic regression model further revealed that sarcopenia was a prognostic factor that was independently associated with both DFS (p = 0.001) and OS (p = 0.006).ConclusionsAmong women with TNBC, sarcopenia is associated with worse clinical outcomes. These patients with high risk might be candidates for individual programmed exercise and diet interventions to optimize survival outcomes.https://www.frontiersin.org/articles/10.3389/fonc.2025.1402300/fullsarcopeniatriple-negative breast cancerTNBCassociationclinical outcomes
spellingShingle Huayan Gu
Teng Zhu
JiaLing Ding
Zhi Yang
Yiqiao Lu
Guilong Guo
The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study
Frontiers in Oncology
sarcopenia
triple-negative breast cancer
TNBC
association
clinical outcomes
title The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study
title_full The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study
title_fullStr The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study
title_full_unstemmed The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study
title_short The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study
title_sort association between sarcopenia and clinical outcomes among chinese patients with triple negative breast cancer a retrospective study
topic sarcopenia
triple-negative breast cancer
TNBC
association
clinical outcomes
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1402300/full
work_keys_str_mv AT huayangu theassociationbetweensarcopeniaandclinicaloutcomesamongchinesepatientswithtriplenegativebreastcanceraretrospectivestudy
AT tengzhu theassociationbetweensarcopeniaandclinicaloutcomesamongchinesepatientswithtriplenegativebreastcanceraretrospectivestudy
AT jialingding theassociationbetweensarcopeniaandclinicaloutcomesamongchinesepatientswithtriplenegativebreastcanceraretrospectivestudy
AT zhiyang theassociationbetweensarcopeniaandclinicaloutcomesamongchinesepatientswithtriplenegativebreastcanceraretrospectivestudy
AT yiqiaolu theassociationbetweensarcopeniaandclinicaloutcomesamongchinesepatientswithtriplenegativebreastcanceraretrospectivestudy
AT guilongguo theassociationbetweensarcopeniaandclinicaloutcomesamongchinesepatientswithtriplenegativebreastcanceraretrospectivestudy
AT huayangu associationbetweensarcopeniaandclinicaloutcomesamongchinesepatientswithtriplenegativebreastcanceraretrospectivestudy
AT tengzhu associationbetweensarcopeniaandclinicaloutcomesamongchinesepatientswithtriplenegativebreastcanceraretrospectivestudy
AT jialingding associationbetweensarcopeniaandclinicaloutcomesamongchinesepatientswithtriplenegativebreastcanceraretrospectivestudy
AT zhiyang associationbetweensarcopeniaandclinicaloutcomesamongchinesepatientswithtriplenegativebreastcanceraretrospectivestudy
AT yiqiaolu associationbetweensarcopeniaandclinicaloutcomesamongchinesepatientswithtriplenegativebreastcanceraretrospectivestudy
AT guilongguo associationbetweensarcopeniaandclinicaloutcomesamongchinesepatientswithtriplenegativebreastcanceraretrospectivestudy